226 related articles for article (PubMed ID: 32277284)
21. Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.
Itzcovich T; Xi Z; Martinetto H; Chrem-Méndez P; Russo MJ; de Ambrosi B; Uchitel OD; Nogués M; Silva E; Rojas G; Bagnatti P; Amengual A; Campos J; Rogaeva E; St George-Hyslop P; Allegri R; Sevlever G; Surace EI
Neurobiol Aging; 2016 Apr; 40():192.e13-192.e15. PubMed ID: 26925510
[TBL] [Abstract][Full Text] [Related]
22. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
[TBL] [Abstract][Full Text] [Related]
23. Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.
Dedeene L; Van Schoor E; Ospitalieri S; Ronisz A; Weishaupt JH; Otto M; Ludolph AC; Scheuerle A; Vandenberghe R; Van Damme P; Poesen K; Thal DR
Acta Neuropathol; 2020 Nov; 140(5):777-781. PubMed ID: 32862270
[No Abstract] [Full Text] [Related]
24. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity.
Kramer NJ; Haney MS; Morgens DW; Jovičić A; Couthouis J; Li A; Ousey J; Ma R; Bieri G; Tsui CK; Shi Y; Hertz NT; Tessier-Lavigne M; Ichida JK; Bassik MC; Gitler AD
Nat Genet; 2018 Apr; 50(4):603-612. PubMed ID: 29507424
[TBL] [Abstract][Full Text] [Related]
25. FTD and ALS: genetic ties that bind.
Orr HT
Neuron; 2011 Oct; 72(2):189-90. PubMed ID: 22017980
[TBL] [Abstract][Full Text] [Related]
26. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
[TBL] [Abstract][Full Text] [Related]
27. Measuring Repeat-Associated Non-AUG (RAN) Translation.
Wang S; Sun S
Methods Mol Biol; 2022; 2428():113-132. PubMed ID: 35171477
[TBL] [Abstract][Full Text] [Related]
28. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
29. Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.
Nordin A; Akimoto C; Wuolikainen A; Alstermark H; Jonsson P; Birve A; Marklund SL; Graffmo KS; Forsberg K; Brännström T; Andersen PM
Hum Mol Genet; 2015 Jun; 24(11):3133-42. PubMed ID: 25712133
[TBL] [Abstract][Full Text] [Related]
30. The Genetics of
Gijselinck I; Cruts M; Van Broeckhoven C
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130313
[TBL] [Abstract][Full Text] [Related]
31. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
Gitler AD; Tsuiji H
Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
[TBL] [Abstract][Full Text] [Related]
32. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
33. CaBagE: A Cas9-based Background Elimination strategy for targeted, long-read DNA sequencing.
Wallace AD; Sasani TA; Swanier J; Gates BL; Greenland J; Pedersen BS; Varley KE; Quinlan AR
PLoS One; 2021; 16(4):e0241253. PubMed ID: 33830997
[TBL] [Abstract][Full Text] [Related]
34. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD.
Tang X; Toro A; T G S; Gao J; Chalk J; Oskarsson B; Zhang K
Mol Neurodegener; 2020 Jun; 15(1):34. PubMed ID: 32513219
[TBL] [Abstract][Full Text] [Related]
35. von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion.
Yang Y; Halliday GM; Hodges JR; Tan RH
J Alzheimers Dis; 2017; 58(3):701-709. PubMed ID: 28482638
[TBL] [Abstract][Full Text] [Related]
36. The frequency of the C9orf72 expansion in a Brazilian population.
Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
[TBL] [Abstract][Full Text] [Related]
37. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
[TBL] [Abstract][Full Text] [Related]
38. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.
Konopka A; Atkin JD
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322030
[TBL] [Abstract][Full Text] [Related]
39. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
[TBL] [Abstract][Full Text] [Related]
40. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers.
Fournier C; Barbier M; Camuzat A; Anquetil V; Lattante S; Clot F; Cazeneuve C; Rinaldi D; Couratier P; Deramecourt V; Sabatelli M; Belliard S; Vercelletto M; Forlani S; Jornea L; ; ; Leguern E; Brice A; Le Ber I
Neurobiol Aging; 2019 Feb; 74():234.e1-234.e8. PubMed ID: 30337192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
